Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
serves patients in and around: Hartford CT, East Hartford CT, South Windsor CT, Manchester CT, West Hartford CT, Farmington CT, Avon CT, Simsbury CT, Wethersfield CT, Bloomfield CT, Newington CT, Windsor CT, Rocky Hill CT, Bristol CT, East Glastonbury CT, South Glastonbury CT
Obesity increases the risk of psychiatric disorders, and mental health conditions affect weight management challenges
Novo Nordisk effectively created the modern obesity drug market with the launch of WEGOVY (semaglutide) in 2021, transforming obesity management from a lifestyle-focused intervention into a highly effective pharmacological treatment option
Ivar Rnnestad, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
